Basic information Safety Supplier Related

4-[(4-Methylpiperazin-1-yl)methyl]aniline

Basic information Safety Supplier Related

4-[(4-Methylpiperazin-1-yl)methyl]aniline Basic information

Product Name:
4-[(4-Methylpiperazin-1-yl)methyl]aniline
Synonyms:
  • 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-ANILINE
  • 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-PHENYLAMINE
  • AKOS BB-8955
  • 4-(4-Methylpiperazin-1-ylmethyl)phenylamine95%
  • 4-(4-METHYLPIPERAZIN-1-YLMETHYL)PHENYLAMINE 95%
  • 4-((4-methylpiperazin-1-yl)methyl)benzenamine
  • 1-(4-Aminobenzyl)-4-methylpiperazine
  • Benzenamine, 4-[(4-methyl-1-piperazinyl)methyl]-
CAS:
70261-82-4
MF:
C12H19N3
MW:
205.3
EINECS:
200-158-5
Mol File:
70261-82-4.mol
More
Less

4-[(4-Methylpiperazin-1-yl)methyl]aniline Chemical Properties

Melting point:
97-99oC
Boiling point:
331.2±27.0 °C(Predicted)
Density 
1.085±0.06 g/cm3(Predicted)
storage temp. 
2-8°C(protect from light)
solubility 
Chloroform (Slightly), Methanol (Slightly)
pka
7.65±0.10(Predicted)
form 
Solid
color 
Yellow
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36
Safety Statements 
26
HazardClass 
IRRITANT
HS Code 
2922390090
More
Less

4-[(4-Methylpiperazin-1-yl)methyl]aniline Usage And Synthesis

Uses

4-(4-Methylpiperazin-1-ylmethyl)phenylamine is an intermediate used to prepare aminopyridopyrimidinones as tyrosine kinase inhibitors and anticancer agents. It is also used in the synthesis of piperazinyltrifluoromethylphenylquinolinylbenzonaphthyridinone derivatives with anticancer activities.

Synthesis

70261-81-3

70261-82-4

Step 2: Preparation of 4-(4-methylpiperazin-1-ylmethyl)aniline (F652-02) 1-Methyl-4-(4-nitrobenzyl)piperazine (F652-01, 4.67 g, 19.9 mmol), methanol (100 mL), zinc powder (6.5 g, 99.3 mmol), and ammonium chloride (4.3 g, 79.5 mmol) were added to a reaction vessel and heated and refluxed for 2 hours. After completion of the reaction, it was cooled to room temperature and the reaction mixture was filtered through diatomaceous earth. The filtrate was distilled under reduced pressure to remove the solvent to give a solid product. Diethyl ether was added to the solid and the insoluble material was removed by filtration. The filtrate was distilled to remove the solvent to give 4-(4-methylpiperazin-1-ylmethyl)aniline (F652-02, white solid, 3.16 g, 77% yield). LC/MS (Method 6): m/z (ESI, POS): 206 [M + H]+; retention time: 1.15 min. 1H-NMR (400 MHz, DMSO-d6) δ 2.12 (s, 3H), 2.29 (bs, 8H), 3.23 (s, 2H), 4.93 (s, 2H), 6.49 (d, J = 8.4 Hz, 2H), 6.89 (d, J = 8.4 Hz, 2H).

References

[1] European Journal of Medicinal Chemistry, 2011, vol. 46, # 7, p. 2917 - 2929
[2] Patent: WO2004/46120, 2004, A2. Location in patent: Page 173
[3] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 15, p. 5738 - 5748
[4] Journal of Medicinal Chemistry, 2017, vol. 60, # 21, p. 8801 - 8815
[5] Journal of Medicinal Chemistry, 2018, vol. 61, # 4, p. 1499 - 1518

4-[(4-Methylpiperazin-1-yl)methyl]aniline Preparation Products And Raw materials

Raw materials

4-[(4-Methylpiperazin-1-yl)methyl]anilineSupplier

BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Shangchem Co., Ltd.
Tel
+86-21-68182121
Accela ChemBio Co.,Ltd.
Tel
021-50795510 4000665055
Email
sales@accelachem.com
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn
skychemical Co.Ltd
Tel
021-20958197 20965099
Email
sales@skychemical.com